Table 1.
Patients’ baseline demographics by study group
| All n = 40 | Treatment group n = 20 | Control group n = 20 | P value | |
|---|---|---|---|---|
| Median (IQR) | Median (IQR) | Median (IQR) | ||
| Sex (male/female) | 19/1 | 19/1 | ||
| Age (years) | 38.0(30.0–47.5) | 34.5(29.3–43.0) | 39.0(31.5–49.0) | 0.198 |
| Body height (cm) | 170.50(166.0–175.8) | 171.0(168.0–175.0) | 169.0(165.0–178.8) | 0.655 |
| Body weight (kg) | 76.2(68.5–90.0) | 76.2(72.3–88.3) | 76.0(65.8–91.5) | 0.797 |
| BMI (kg/m2) | 26.4(24.2–29.1) | 26.5(24.2–29.0) | 26.4(23.8–29.3) | 0.978 |
| SBP (mmHg) | 130.0(122.3–139.8) | 126.0(121.3–136.8) | 132.5(126.5–141.5) | 0.163 |
| DBP (mmHg) | 84.0(72.8–88.0) | 81.0(70.3–88.0) | 85.0(79.3–88.8) | 0.302 |
| WBC (/μl) | 8725(7125–10275) | 8910(7515–10115) | 8725(6622–10525) | 0.776 |
| RBC (104/μl) | 520.5(480–535) | 525.0(491.3–556.5) | 501.0(468.3–528.8) | 0.079 |
| Hb (g/dl) | 14.9(14.3–15.7) | 15.1(14.0–16.1) | 14.8(14.3–15.7) | 0.871 |
| Hct (%) | 44.0(41.8–45.8) | 43.9(41.5–46.6) | 44.1(42.6–45.7) | 0.685 |
| MCV (fl) | 87.0(84.3–90.3) | 85.8(83.4–87.6) | 87.8(85.7–92.0) | 0.022 |
| MCH (Pg) | 29.4(29.0–30.7) | 29.4(28.8–30.1) | 30.4(29.1–31.0) | 0.104 |
| MCHC (g/dl) | 33.9(33.5–34.5) | 34.2(33.5–34.8) | 33.7(33.5–34.3) | 0.316 |
| Platelet (/μl) | 236.5 K(211 K–267.5 K) | 243.5 K(205 K–261.5 K) | 234.5 K(212 K–269 K) | 0.756 |
| GPT (IU/l) | 29.5(17.0–41.8) | 31.0(13.8–37.0) | 28.0(17.0–43.8) | 0.498 |
| Creatine (mg/dl) | 1.00(0.9–1.1) | 1.0(0.9–1.1) | 0.9(0.8–1.0) | 0.182 |
| CRP (mg/dl) | 0.6(0.2–1.7) | 0.5(0.2–1.3) | 0.7(0.5–1.9) | 0.351 |
| Uric acid (mg/dl) | 7.3(5.9–8.3) | 7.3(5.9–8.3) | 7.4(5.9–8.4) | 0.892 |
| VAS | 5.0(3.0–8.0) | 5.5(3.6, 9.0) | 5.0(3.0–7.0) | 0.241 |
BMI body mass index, CRP C-reactive protein, DBP diastolic blood pressure, GPT glutamic pyruvic transaminase, Hb hemoglobin, Hct hematocrit, MCV mean corpuscular volume, MCH mean corpuscular hemoglobin, RBC red blood cell, SBP systolic blood pressure, WBC white blood cell
aMann–Whitney U test for the difference compared between the treatment group and control group
*P < 0.05